PT283 – Greg McKee – Psychedelics for Nociplastic Pain

In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.  

www.psychedelicstoday.com